Lawsuit for Elanco Animal Health (NYSE: ELAN) Investors: Contact Shareholders Foundation for More Information

2 min read | November 19, 2024 10:30 AM PST | By Team Kalkine Media

Google News:

Lawsuit for Elanco Animal Health (NYSE: ELAN) Investors: Contact Shareholders Foundation for More Information — Image source: Shutterstock

Recent News

JPMorgan (NYSE:JPM) Leads Quiet Rotation In Financial Value Stocks

Exxon Mobil (NYSE:XOM) In Focus: What’s Catching Market Attention?

UnitedHealth (NYSE:UNH) Leads Healthcare Value Watch

Duke Energy (NYSE:DUK) Dividends Face A Key Market Test

Make Kalkine Media
My Trusted Source

Highlights:

A lawsuit is currently underway involving certain shareholders of Elanco Animal Health Incorporated (NYSE:ELAN).

The lawsuit claims that the company made false or misleading statements regarding its products, including Zenrelia and Credelio Quattro.

Shareholders who purchased shares prior to November 2023 and continue to hold those shares may have legal options available.

A class action lawsuit is currently pending for certain shareholders of Elanco Animal Health Incorporated (NYSE:ELAN) . The lawsuit, filed on June 26, 2024, accuses the company of violating securities laws by making false and misleading statements, or failing to disclose material facts, about its products and business prospects.

The plaintiff alleges that Elanco misled shareholders by overstating the safety and approval prospects of its veterinary products, particularly Zenrelia. The lawsuit further claims that the company was unlikely to meet its self-imposed timeline for receiving U.S. approval and launching both Zenrelia and Credelio Quattro. According to the plaintiff, Elanco's public statements about the business and financial outlook were materially misleading, as they failed to disclose these challenges, resulting in overstated expectations.

Elanco’s product Zenrelia, which was touted as a key offering, allegedly posed greater safety risks than the company had indicated. Additionally, the lawsuit asserts that the company's projections for the product’s approval and launch were unrealistic, potentially impacting its financial performance.

Shareholders who purchased shares of Elanco prior to November 2023 and continue to hold those shares may have legal options available. They are encouraged to contact the Shareholders Foundation for more information regarding the lawsuit and potential next steps. The Shareholders Foundation provides legal monitoring and support for individuals involved in securities class actions, offering assistance in navigating potential claims.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.